Health and Fitness Health and Fitness
Mon, November 21, 2011
[ Mon, Nov 21st 2011 ] - Market Wire
Dendreon Announces the Centers for Medicare and M .. ow Cover Infusion Costs Associated with the Admin
[ Mon, Nov 21st 2011 ] - Market Wire
Tengion to Present at Piper Jaffray 23rd Annual Health Care Conference
[ Mon, Nov 21st 2011 ] - Market Wire
InVivo Therapeutics and Cord Blood America Receive Boost in Support as Geron Changes Strategy
[ Mon, Nov 21st 2011 ] - Market Wire
Celldex Therapeutics Reports Positive Mature Surv .. ndopepimut Phase 2 Brain Cancer Study at SNO 2011
[ Mon, Nov 21st 2011 ] - Market Wire
Research on Health Management Associates Inc. and .. . -- Healthcare Hospitals Report Mixed Q3 Results
[ Mon, Nov 21st 2011 ] - Market Wire
BioSante Pharmaceuticals Added to NASDAQ Biotechnology Index
[ Mon, Nov 21st 2011 ] - Market Wire
REVLIMID riceve approvazione di Swissmedic per il trattamento di un raro cancro del sangue
[ Mon, Nov 21st 2011 ] - Market Wire
REVLIMID Granted Swissmedic Approval for Treatment of Rare Blood Cancer
[ Mon, Nov 21st 2011 ] - Market Wire
BioDelivery Sciences to Present at the 23rd Annual Piper Jaffray Healthcare Conference
[ Mon, Nov 21st 2011 ] - Market Wire
Gilead Sciences to Acquire Pharmasset, Inc. for $11 Billion
[ Mon, Nov 21st 2011 ] - Market Wire
ArthroCare Announces Participation in Investor Conference
[ Mon, Nov 21st 2011 ] - Market Wire
Implant Sciences' Quantum Sniffer(TM) Explosives .. New Mobile Airfreight Screening Business in Germa
[ Mon, Nov 21st 2011 ] - Market Wire
Oncolytics Biotech Inc. Announces Start of Conformity Testing with SAFC
[ Mon, Nov 21st 2011 ] - Market Wire
Mylan Announces Settlement Agreement for its First-to-File Generic Version of Vivelle-Dot
[ Mon, Nov 21st 2011 ] - Market Wire
Adeona Pharmaceuticals and Intrexon Announce Worl .. for Synthetic DNA-based Therapy for Pulmonary Ar
[ Mon, Nov 21st 2011 ] - Market Wire
Preclinical Darinaparsin Study in PLoS ONE Publication
[ Mon, Nov 21st 2011 ] - Market Wire
Health Management Associates, Inc. Announces Clos .. ties, Private $875 Million Debt Offering and GAAP
[ Mon, Nov 21st 2011 ] - Market Wire
OncoSec Appoints Scientific Advisory Board
[ Mon, Nov 21st 2011 ] - Market Wire
Alnylam Presents Positive Preliminary Clinical Re .. Therapeutic for the Treatment of Transthyretin-Me
[ Mon, Nov 21st 2011 ] - Market Wire
Perceptive Informatics Global Survey Results Indi .. ndard Medical Imaging Metrics to Meet Study Miles
[ Mon, Nov 21st 2011 ] - Market Wire
PowerVerde Announces Binding Letter of Intent to .. tion Group, a Technology and Distribution Company
[ Mon, Nov 21st 2011 ] - Market Wire
Exelixis Announces Initiation of Phase 2 Investig .. antinib in Women with Hormone Receptor-Positive M
[ Mon, Nov 21st 2011 ] - Market Wire
Comprehensive Care Corporation Announces Nine Month Revenues Top $54 Million, up 212 Percent
Sun, November 20, 2011
[ Sun, Nov 20th 2011 ] - Market Wire
Valeant Pharmaceuticals Agrees to Acquire iNova
[ Sun, Nov 20th 2011 ] - Market Wire
CML HealthCare Inc. Declares November Dividend
Fri, November 18, 2011
[ Fri, Nov 18th 2011 ] - Market Wire
Warnex Reaches Agreement to Extend Maturity Date .. ing Debentures and to Obtain Additional Financing
[ Fri, Nov 18th 2011 ] - Market Wire
Quidel to Present at 23rd Annual Piper Jaffray Health Care Conference
[ Fri, Nov 18th 2011 ] - Market Wire
Regeneron Announces FDA Approval of EYLEAa" (afli .. Treatment of Wet Age-Related Macular Degeneration
[ Fri, Nov 18th 2011 ] - Market Wire
Cigna Announces Leadership Changes
[ Fri, Nov 18th 2011 ] - Market Wire
Orthofix International to Participate in the 23rd Annual Piper Jaffray Healthcare Conference

Orthofix International to Participate in the 23rd Annual Piper Jaffray Healthcare Conference


Published on 2011-11-18 13:11:43 - Market Wire
  Print publication without navigation


LEWISVILLE, Texas--([ ])--Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today that it will participate in the 23rd Annual Piper Jaffray Healthcare Conference on Wednesday, November 30th at 3:30 PM Eastern Time at the New York Palace in New York, NY.

A live audio webcast will be available on the Companyas website at [ www.orthofix.com ] by clicking on the Investors tab and then clicking the link on the Events & Presentations page.

About Orthofix

Orthofix International N.V. is a global medical device company offering a broad line of minimally invasive surgical, and non-surgical products for the spine, orthopedics, and sports medicine market sectors that address the lifelong bone-and-joint health needs of patients of all ages helping them achieve a more active and mobile lifestyle. Orthofixas products are widely distributed around the world to orthopedic surgeons and patients via Orthofixas sales representatives and its subsidiaries, including BREG, Inc., and via collaborations with other leading orthopedic product companies. In addition, Orthofix is collaborating on R&D activities with leading research and clinical organizations such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation, Texas Scottish Rite Hospital for Children, and the Cleveland Clinical Foundation. For more information about Orthofix, please visit [ www.orthofix.com ].

Contributing Sources